(Q40238946)

English

Differential tumor suppressor properties and transforming growth factor-beta responsiveness of p57KIP2 in leukemia cells with aberrant p57KIP2 promoter DNA methylation

scientific article published on 28 August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Differential tumor suppressor properties and transforming growth factor-beta responsiveness of p57KIP2 in leukemia cells with aberrant p57KIP2 promoter DNA methylation (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

DNA methylation

0 references

author name string

Kuang SQ

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Ling X

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sanchez-Gonzalez B

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Yang H

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Andreeff M

5

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Garcia-Manero G

6

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

language of work or name

0 references

publication date

28 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1439-1448

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Aberrant DNA methylation of a cell cycle regulatory pathway composed of P73, P15 and P57KIP2 is a rare event in children with acute lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

Concurrent methylation of multiple genes in childhood ALL: Correlation with phenotype and molecular subgroup.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

Deletion of the cancer-amplified coactivator AIB3 results in defective placentation and embryonic lethality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

Characterization of the human p57KIP2 gene: alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

Methylation profiling in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

COBRA: a sensitive and quantitative DNA methylation assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

Antileukemia activity of the combination of 5-aza-2'-deoxycytidine with valproic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

21 January 2018

Protein expression of a triad of frequently methylated genes, p73, p57Kip2, and p15, has prognostic value in adult acute lymphocytic leukemia independently of its methylation status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

7 January 2021

based on heuristic

inferred from DOI database lookup

Mice lacking a CDK inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

7 January 2021

based on heuristic

inferred from DOI database lookup

Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209907

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1209907

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40238946&oldid=2203528053"